Costs could go up for API distributors in Europe

02/24/2013 |

Firms that transport active pharmaceutical ingredients in European Union countries could face increased costs of doing business if draft guidelines issued earlier this month are adopted. The guidelines would require distributors to have quality management and risk identification procedures, appoint key personnel at distributions points, be registered under the Falsified Medicines directive and ensure warehouses are capable of protecting shipments, among other provisions.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX